Olaitan Okunoye,Laura Horsfall,Louise Marston et al.
Olaitan Okunoye et al.
Background: Parkinson's disease (PD) is associated with an increased rate of mortality. It is unclear whether this is due to complications and comorbidities associated with the disease or the disease process of PD itself....
Late Cognitive or Mood Alterations With 'Status Cribrosum' and Diffuse White Matter Lesions: A New Cerebral Small Vessel Disease Phenotype Associated With Rare COL4A1 Variants Located Within Exon 23 [0.03%]
“状孔隙脑”和弥漫性白质病变相关的认知或情绪障碍：COL4A1外显子23罕见变异相关的新型脑小血管病表型
Hélène Morel,Sophie Dufourd-Delalande,William Bloch et al.
Hélène Morel et al.
Objective: To report an atypical phenotype associated with two rare COL4A1 glycine missense variants located in exon 23. Methods: Clini...
Plasma Proteomic Changes in GRN and C9orf72 Frontotemporal Dementia [0.03%]
GRN和C9orf72突变型额颞叶痴呆患者血浆蛋白组变化特点研究
Joel Simrén,Andrea L Benedet,Guglielmo Di Molfetta et al.
Joel Simrén et al.
Background: Biomarkers reflecting the complex pathophysiology of genetic frontotemporal dementia (FTD) will be increasingly important with the advent of therapeutic trials aiming to slow or prevent the disease. In this st...
A Novel RORA Hinge-Region Variant in Adult IDDECA With Cerebellar Atrophy and Marked Response to Valproate [0.03%]
成人IDDECA小脑萎缩的新颖RORA铰链区变异及对丙戊酸的强烈反应
V Busco,G Di Lazzaro,A T Cimmino et al.
V Busco et al.
Objectives: To expand the RORA mutational and clinical spectrum by reporting a novel hinge-region variant associated with an adult progressive phenotype and a marked therapeutic response to valproate. ...
Neuropsychological Tests for Detecting Prodromal DLB: A Systematic Review [0.03%]
检测皮克病前驱期的认知测试系统性回顾
Francesco Mori,Fabrizia D&#x;Antonio,Giulia Zazzaro et al.
Francesco Mori et al.
Background: The prodromal phase of Dementia with Lewy bodies (DLB) remains unexplored and poorly defined. This systematic review scrutinised studies on the earliest cognitive DLB deficits, focusing on the most useful neur...
Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab [0.03%]
延长期给药奥克雷珠单抗治疗多发性硬化患者的CD19+B细胞恢复的个体差异
Laura Hogenboom,Lisa G Schoof,Liza M Y Gelissen et al.
Laura Hogenboom et al.
Background and objectives: B-cell repopulation patterns in ocrelizumab treated patients with multiple sclerosis are highly variable between individuals, but the course of B-cell reoccurrence after subsequent doses within ...
Randomized Controlled Trial
European journal of neurology. 2026 Jul;33(7):e70695. DOI:10.1111/ene.70695 2026
Correction to 'Pharmacological Interventions for Hereditary Transthyretin-Related Amyloidosis With Polyneuropathy: Systematic Review and Network Meta-Analysis' [0.03%]
家族性transthyretinATTR多发性神经病的药物干预措施：系统回顾和网状meta分析的更正通知
Published Erratum
European journal of neurology. 2026 Jul;33(7):e70696. DOI:10.1111/ene.70696 2026
Diagnostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in Differentiating Primary From Serious Secondary Headache [0.03%]
神经丝轻链和酸性胶质纤维蛋白在区分原发性和继发性严重头痛中的诊断价值
Sara-Jessica Camerin,Cihan Atila,Claudine A Blum et al.
Sara-Jessica Camerin et al.
Background: Headache is one of the most frequent reasons for emergency department (ED) visits, and distinguishing primary from secondary headache remains challenging. Blood biomarkers may improve early risk stratification...
Multicenter Study
European journal of neurology. 2026 Jul;33(7):e70691. DOI:10.1111/ene.70691 2026
Neuropsychiatric Adverse Events Associated With Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Clinical Practice: A Multicenter Study [0.03%]
临床实践中与左旋多巴/卡比多巴连续皮下输注相关的神经精神不良事件：一项多中心研究
David Campo-Caballero,Jon Rodriguez-Antiguedad,Arnau Puig-Davi et al.
David Campo-Caballero et al.
Background: Foslevodopa/foscarbidopa continuous subcutaneous infusion (LDp/CDp CSI) has emerged as an effective and well-tolerated therapy for reducing OFF and increasing non-troublesome ON in advanced Parkinson's disease...
Observational Study
European journal of neurology. 2026 Jul;33(7):e70693. DOI:10.1111/ene.70693 2026
Transfusion-Associated Graft-Versus-Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy? [0.03%]
克拉溴马林治疗多发性硬化后的输血相关移植物抗宿主病风险和输血需求：修订辐照政策的时候了吗？
Klaus Schmierer,Frederick Chen,David Paling
Klaus Schmierer
Background: Irradiation of cellular blood components prevents transfusion-associated graft-versus-host disease (TA-GVHD). UK and Spanish guidance recommend lifelong irradiation for all patients treated with purine analogu...